Over the first nine months, Aviva’s General Insurance premiums grew 15% to £9.1bn. Sales grew in the Protection & Health and Retirement divisions 22% and 67% respectively, the latter benefitting from a near doubling of bulk annuity volumes to £6.1bn. Wealth net flows were up 21% to £7.7bn.
The solvency II ratio, which measures capital levels compared to requirements, dipped from 205% to 195%.
Medium term guidance, which is looking for operating profit of £2bn by 2026, was unchanged.
The shares rose 2.8% in early trading.
Our view
HL view to follow.
Aviva key facts
All ratios are sourced from Refinitiv, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.
This article is not advice or a recommendation to buy, sell or hold any investment.No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment.This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication.Non - independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place(including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing.Please see our full non - independent research disclosure for more information.